Glycoprotein IIb/IIIa polymorphism in type-2 diabetic patients with and without myocardial infarction

被引：0
|
作者：
Eibl, N
Streit, G
Krugluger, W
Hopmeier, P
Schernthaner, G
机构：
[1] Rudolfstiftung Hosp, Dept Med 1, A-1030 Vienna, Austria
[2] Rudolfstiftung Hosp, Dept Clin Chem, A-1030 Vienna, Austria
来源：
DIABETOLOGIA | 2000年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
340
引用
收藏
页码：A86 / A86
页数：1
相关论文
共 50 条
  • [31] Association of the platelet PIA polymorphism of glycoprotein IIb/IIIa and the fibrinogen B beta 448 polymorphism with myocardial infarction and extent of coronary artery disease
    Carter, AM
    OsseiGerning, N
    Wilson, IJ
    Grant, PJ
    CIRCULATION, 1997, 96 (05) : 1424 - 1431
  • [32] PLATELET GLYCOPROTEIN IIB-IIIA AND SIZE ARE INCREASED IN ACUTE MYOCARDIAL-INFARCTION
    GILES, H
    SMITH, REA
    MARTIN, JF
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (01) : 69 - 72
  • [33] Intralesional delivery of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction: Review and recommendations
    Kirresh, Ali
    Candilio, Luciano
    Stone, Gregg W.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2022, 99 (03) : 641 - 649
  • [34] Acute myocardial infarction in a patient with essential thrombocythemia treated with glycoprotein IIb/IIIa inhibitor
    Gül, Ç
    Kürüm, T
    Demir, M
    Özbay, G
    Vural, Ö
    Iqbal, O
    Fareed, J
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2004, 10 (01) : 77 - 79
  • [35] Combination therapy for acute myocardial infarction: Fibrinolytic therapy and glycoprotein IIb/IIIa inhibition
    Califf, RM
    AMERICAN HEART JOURNAL, 2000, 139 (02) : S33 - S37
  • [36] Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.
    Montalescot, G
    Barragan, P
    Wittenberg, O
    Ecollan, P
    Elhadad, S
    Villain, P
    Boulenc, JM
    Morice, MC
    Maillard, L
    Pansiéri, M
    Choussat, R
    Pinton, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (25): : 1895 - 1903
  • [37] CLINICAL BENEFIT OF GLYCOPROTEIN IIB/IIIA RECEPTOR INHIBITOR IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION COMPLICATED BY CARDIOGENIC SHOCK
    Sim, Doo Sun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E23 - E23
  • [38] Glycoprotein IIb/IIIa antagonist reduces the extent of irreversible microvascular injury in patients with reperfused acute myocardial infarction
    Ai-Saadi, N
    Dechend, R
    Abdel-Aty, H
    Taylor, A
    Friedrich, MG
    CIRCULATION, 2003, 108 (17) : 580 - 580
  • [39] Glycoprotein IIb/IIIa receptor inhibitors versus bivalirudin in patients with ST-segment elevation myocardial infarction
    Angeras, Oskar
    Ioanes, Dan
    Ramunddal, Truls
    Omerovic, Elmir
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B82 - B82
  • [40] Myocardial salvage after thrombolysis combined with glycoprotein IIb/IIIA blockade versus thrombolysis alone in patients with acute myocardial infarction
    Ndrepepa, G
    Mehilli, J
    Schwaiger, M
    Nekolla, S
    Schmitt, C
    Dirschinger, J
    Schömig, A
    Kastrati, A
    EUROPEAN HEART JOURNAL, 2004, 25 : 355 - 355
12345